XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.clinicaltrialsarena.com/uncategorized/newsmerck-pfizer-enter-into-ertugliflozin-clinical-development-collaboration/20%Daily2013-04-30 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsgtx-commences-enobosarm-phase-ii-metastatic-breast-cancer-study/20%Daily2013-04-30 17:30
https://www.clinicaltrialsarena.com/uncategorized/newspfizer-reports-positive-data-from-phase-iii-study-of-prevenar-13/20%Daily2013-04-29 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsmerrimack-completes-enrolment-in-second-cohort-of-lung-cancer-study/20%Daily2013-04-29 17:30
https://www.clinicaltrialsarena.com/uncategorized/newspfizer-celecoxib-meets-primary-endpoint-in-phase-iv-juvenile-idiopathic-arthritis-trial/20%Daily2013-04-28 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsmorphosys-doses-first-patient-in-phase-ii-trial-of-mor208-leukemia-drug/20%Daily2013-04-28 17:30
https://www.clinicaltrialsarena.com/uncategorized/newslightlake-nida-collaborate-to-develop-opioid-addiction-treatment/20%Daily2013-04-25 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsampio-completes-patient-enrolment-in-osteoarthritis-drug-study/20%Daily2013-04-25 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsgalapagos-commences-phase-iia-ulcerative-colitis-study-of-glpg0974/20%Daily2013-04-24 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsacelrx-phase-ii-study-of-arx-04-meets-primary-endpoint/20%Daily2013-04-24 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsmerck-signs-deal-with-bristol-myers-for-phase-ii-hepatitis-c-trial/20%Daily2013-04-23 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsprothena-doses-first-patient-in-phase-i-study-of-neod001/20%Daily2013-04-23 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsbioinvent-treats-first-patient-in-phase-ii-smoldering-myeloma-study-of-bi-505/20%Daily2013-04-22 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsbind-astrazeneca-to-jointly-develop-accurin-cancer-nanomedicine/20%Daily2013-04-22 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsromark-commences-patient-enrolment-in-phase-iii-trial-of-nt-300-influenza-drug/20%Daily2013-04-21 17:30
https://www.clinicaltrialsarena.com/uncategorized/newscivitas-reports-positive-results-from-phase-ii-trial-of-cvt-301/20%Daily2013-04-21 17:30
https://www.clinicaltrialsarena.com/uncategorized/newstargacept-completes-patient-recruitment-in-tc-5619-phase-2b-schizophrenia-study/20%Daily2013-04-19 02:30
https://www.clinicaltrialsarena.com/uncategorized/newsneuralstem-to-begin-phase-ii-amytrophic-lateral-sclerosis-trial-using-stem-cells/20%Daily2013-04-18 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsasmacure-doses-first-subjects-in-phase-12-trial-of-asm-024/20%Daily2013-04-17 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsuk-court-sentences-pre-clinical-trial-data-scam-case-accused-to-three-months-in-prison/20%Daily2013-04-17 17:30
https://www.clinicaltrialsarena.com/uncategorized/newssantaris-partners-bristol-myers-discover-rna-targeted-medicines/20%Daily2013-04-16 17:30
https://www.clinicaltrialsarena.com/uncategorized/newseli-lilly-reports-positive-top-line-results-from-phase-iii-trials-of-type-2-diabetes-drug/20%Daily2013-04-16 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsmerrimack-completes-patient-enrolment-in-one-cohort-of-phase-2-study-of-breast-cancer-agent/20%Daily2013-04-16 02:30
https://www.clinicaltrialsarena.com/uncategorized/newsneuralgene-assess-amyotrophic-lateral-sclerosisgene-therapy-animal-studies/20%Daily2013-04-15 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsoncogenex-begin-spruce-clinical-trial-ogx-427-cancer-agent/20%Daily2013-04-14 17:30
https://www.clinicaltrialsarena.com/uncategorized/newssirtex-completes-patient-recruitment-in-sirflox-study-to-treat-colorectal-liver-metastases/20%Daily2013-04-14 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsiroko-reports-positive-results-from-phase-iii-submicron-indomethacin-diclofenac-studies/20%Daily2013-04-11 17:30
https://www.clinicaltrialsarena.com/uncategorized/newssorbent-initiates-phase-iib-trial-of-clp-1001-in-heart-failure-patients/20%Daily2013-04-11 17:30
https://www.clinicaltrialsarena.com/uncategorized/newspivotal-vascazen-reveal-trial-meets-primary-endpoint/20%Daily2013-04-10 17:30
https://www.clinicaltrialsarena.com/uncategorized/newssunshine-anticancer-compound-demonstrates-non-toxicity-at-high-concentrations/20%Daily2013-04-10 17:30
https://www.clinicaltrialsarena.com/uncategorized/newslipocine-announces-positive-phase-i-oral-testosterone-study-results/20%Daily2013-04-09 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsreviva-announces-positive-rp5063-phase-ii-trial-data/20%Daily2013-04-09 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsvertex-bristol-myers-sign-deal-to-conduct-phase-ii-hepatitis-c-all-oral-studies/20%Daily2013-04-08 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsspectrum-commences-phase-ii-study-of-chemotherapy-induced-neutropenia-drug/20%Daily2013-04-08 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsastellas-collaborates-with-ambrx-for-antibody-drug-conjugates-development/20%Daily2013-04-07 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsastrazeneca-reports-top-line-results-phase-3-ra-study-fostamatinib/20%Daily2013-04-07 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsaragon-doses-first-patient-in-phase-i-breast-cancer-study-of-arn-810/20%Daily2013-04-04 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsaastrom-enrols-first-patients-in-ixcell-dcm-clinical-trial/20%Daily2013-04-04 17:30
https://www.clinicaltrialsarena.com/uncategorized/newstaris-begins-dosing-in-second-phase-ii-study-with-liris/20%Daily2013-04-03 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsisis-commences-phase-i-study-of-atherosclerosis-drug/20%Daily2013-04-03 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsprotalix-initiates-treatment-in-phase-i-gaucher-disease-study-of-prx-112/20%Daily2013-04-02 17:30
https://www.clinicaltrialsarena.com/uncategorized/newstheravida-sk-chemicals-sign-licensing-deal-for-overactive-bladder-medicines/20%Daily2013-04-02 17:30
https://www.clinicaltrialsarena.com/uncategorized/newscurevac-commences-phase-iib-prostate-cancer-trial-of-cv9104/20%Daily2013-04-01 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsaxelar-axl-003-demonstrates-efficacy-in-second-line-treatment-of-lung-cancer-patients/20%Daily2013-04-01 17:30